Heranba Launches Crop Nutrition Products, Targets ₹2,500 Crore Turnover

CHEMICALS
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Heranba Launches Crop Nutrition Products, Targets ₹2,500 Crore Turnover
Overview

Heranba Industries has entered the crop nutrition segment with the launch of two new products, 'Fentaamine' (bio stimulant) and 'MycoHil' (biofertilizer). The company aims to achieve a significant turnover of ₹2,500 crore in the current fiscal year (FY27), aligning with its Vision 2026 growth roadmap. This strategic move is accompanied by plans to expand its global footprint across over 80 countries and establish a subsidiary in Dubai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Heranba Industries Ventures into Crop Nutrition, Targets ₹2,500 Crore Turnover

New Crop Nutrition Products

Heranba Industries has officially entered the crop nutrition sector, introducing two new products. 'Fentaamine' is a bio stimulant designed to boost plant growth and stress tolerance, while 'MycoHil' is a biofertilizer aimed at improving soil health and nutrient absorption. This expansion supports the company's ambitious revenue target of ₹2,500 crore for fiscal year 2027 and includes plans for greater global reach.

Market Opportunity

This strategic diversification moves Heranba beyond its traditional agrochemicals into the rapidly growing crop nutrition market, which emphasizes sustainability. Demand is increasing as farmers focus more on soil health, seek higher yields, and align with global trends towards organic and balanced farming methods.

Company Background

Founded in 1992, Heranba Industries is an established agrochemical manufacturer known for synthetic pyrethroids, insecticides, herbicides, and fungicides. The company operates integrated production facilities in Gujarat, guided by its Vision 2026 growth plan, and has developed a strong reputation for its complete product value chain, from intermediates to finished formulations.

Key Strategic Moves

  • Product Diversification: Introducing 'Fentaamine' and 'MycoHil' creates new avenues for revenue.
  • Revenue Growth: The target of ₹2,500 crore turnover for FY27 indicates an aggressive growth path.
  • Global Expansion: The company plans to expand its presence to over 80 countries and set up a subsidiary in Dubai.
  • Farmer Support: New products aim to improve farm productivity and sustainability.

Potential Risks

  • Regulatory and Economic Factors: The company's future outlook is subject to risks from potential regulatory shifts and economic or political developments.
  • Payment Disputes: Heranba and a subsidiary are facing insolvency petitions from Haresh Petrochem Private Limited concerning outstanding payments. Hearings are scheduled.
  • Environmental and Compliance Concerns: The company has encountered criminal proceedings related to environmental regulations and allegations of product misbranding under the Insecticides Act.

Competitive Landscape

Heranba operates in a dynamic agrochemical market alongside major companies such as UPL Ltd, PI Industries Ltd, Coromandel International Ltd, and Rallis India Ltd. The crop nutrition sector is seeing global growth, with competitors also investing in specialized solutions for sustainable agriculture.

Recent Financial Snapshot

  • Trailing twelve months (TTM) Revenue: ₹1,610.3 Cr as of April 2026 (Consolidated).
  • TTM Net Profit: ₹-60.9 Cr as of April 2026 (Consolidated).

Looking Ahead

  • Market reception and sales results for the new crop nutrition products, 'Fentaamine' and 'MycoHil'.
  • Progress in meeting the ₹2,500 crore revenue goal for FY27.
  • Updates on establishing the Dubai subsidiary and expanding into new international markets.
  • Outcomes of the pending insolvency petitions and other legal matters.
  • Performance of expanded production facilities and R&D efforts.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.